Literature DB >> 8185406

A new approach to parathyroidectomy.

G L Irvin1, D L Prudhomme, G T Deriso, G Sfakianakis, S K Chandarlapaty.   

Abstract

OBJECTIVE: To decrease the operative time for parathyroidectomy in patients with hypercalcemic (primary) hyperparathyroid disease, a combination of preoperative localization of a parathyroid tumor with an effective nuclear scan (scintigram) and intraoperative monitoring of parathyroid hormone (quick parathyroid hormone measurement) to ensure excision of all hyperfunctioning tissue was studied. SUMMARY BACKGROUND DATA: For many years, persistent hypercalcemia after parathyroidectomy (3% to 10%) has been constant and is usually due to the surgeon's failure to remove all hyperfunctioning glands. A marked decrease in parathormone level after excision of a single large gland predicts operative success and a return to normal calcium levels. Conversely, persistent high levels of parathyroid hormone indicate excess secretion by another gland(s) and the need for further exploration. Recently Tc-99m-sestamibi (MIBI) scintigraphy was shown to be more effective in localizing parathyroid tumors than previous methods. A combination of both techniques could be useful to the surgeon if they improve the operative success rate and are cost-effective.
METHODS: Parathyroidectomy was performed on 18 patients with primary hyperparathyroid disease, with tumors localized by MIBI scintigrams. When excision of the identified parathyroid gland was accomplished, the operation was terminated and quick parathyroid hormone was measured to confirm that all hyperfunctioning tissue was removed.
RESULTS: Sixteen patients with positive results of scintigram had successful parathyroidectomies confirmed by quick parathyroid hormone measurement with a cervical approach. Two patients with mediastinal tumors localized by MIBI scintigraphy could not be resected using this approach. One false-positive/false-negative scintigram was obtained. Compared with patients having parathyroidectomy without localization and hormone monitoring, the average operative time was shortened from 90 to 36 minutes.
CONCLUSIONS: Localization and successful excision of parathyroid tumors with confirmation that no other hyperfunctioning glands were present by quick parathyroid hormone monitoring can predict a return to normal calcium levels and a decrease in operative time in parathyroidectomy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8185406      PMCID: PMC1243192          DOI: 10.1097/00000658-199405000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  Single and multigland disease in primary hyperparathyroidism: clinical follow-up, histopathology, and flow cytometric DNA analysis.

Authors:  H J Bonjer; H A Bruining; J C Birkenhager; R H Nishiyama; M A Jones; C B Bagwell
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

2.  Initial failure of surgical exploration in patients with primary hyperparathyroidism.

Authors:  L J Auguste; J N Attie; D Schnaap
Journal:  Am J Surg       Date:  1990-10       Impact factor: 2.565

3.  High-performance immunoaffinity chromatography and chemiluminescent detection in the automation of a parathyroid hormone sandwich immunoassay.

Authors:  D S Hage; P C Kao
Journal:  Anal Chem       Date:  1991-03-15       Impact factor: 6.986

4.  Operative monitoring of parathyroid gland hyperfunction.

Authors:  G L Irvin; V D Dembrow; D L Prudhomme
Journal:  Am J Surg       Date:  1991-10       Impact factor: 2.565

5.  99Tcm sestamibi--a new agent for parathyroid imaging.

Authors:  A J Coakley; A G Kettle; C P Wells; M J O'Doherty; R E Collins
Journal:  Nucl Med Commun       Date:  1989-11       Impact factor: 1.690

6.  Cervical exploration for primary hyperparathyroidism.

Authors:  A R Shaha; B M Jaffe
Journal:  J Surg Oncol       Date:  1993-01       Impact factor: 3.454

7.  Multiglandular disease in seemingly sporadic primary hyperparathyroidism revisited: where are we in the early 1990s? A plea against unilateral parathyroid exploration.

Authors:  C A Proye; B Carnaille; J P Bizard; J L Quievreux; M Lecomte-Houcke
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

8.  Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study)

Authors:  R Taillefer; Y Boucher; C Potvin; R Lambert
Journal:  J Nucl Med       Date:  1992-10       Impact factor: 10.057

9.  Clinical usefulness of an intraoperative "quick parathyroid hormone" assay.

Authors:  G L Irvin; V D Dembrow; D L Prudhomme
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

10.  Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands.

Authors:  J P Wei; G J Burke; A R Mansberger
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

View more
  42 in total

1.  Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease.

Authors:  Thomas Clerici; Michael Brandle; Jochen Lange; Gerard M Doherty; Paul G Gauger
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

2.  The false-positive parathyroid sestamibi: a real or perceived problem and a case for radioguided parathyroidectomy.

Authors:  J G Norman; C E Jaffray; H Chheda
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  Intraoperative monitoring of intact PTH in surgery for renal hyperparathyroidism as an indicator of complete parathyroid removal.

Authors:  Miguel Echenique Elizondo; Francisco Javier Díaz-Aguirregoitia; José Antonio Amondarain; Fernando Vidaur
Journal:  World J Surg       Date:  2005-11       Impact factor: 3.352

4.  Unexpected results using rapid intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism.

Authors:  Ignazio Emmolo; Herbert Dal Corso; Giorgio Borretta; Gianluca Visconti; Alessandro Piovesan; Flora Cesario; Felice Borghi
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

5.  Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial.

Authors:  Anders Bergenfelz; Pia Lindblom; Sten Tibblin; Johan Westerdahl
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

6.  Predictive value of intact parathyroid hormone measurement during surgery for renal hyperparathyroidism.

Authors:  Daniel Seehofer; Nada Rayes; Jochen Klupp; Thomas Steinmüller; Frank Ulrich; Christian Müller; Ralph Schindler; Ulrich Frei; Peter Neuhaus
Journal:  Langenbecks Arch Surg       Date:  2005-02-22       Impact factor: 3.445

7.  The small abnormal parathyroid gland is increasingly common and heralds operative complexity.

Authors:  Kelly L McCoy; Naomi H Chen; Michaele J Armstrong; Gina M Howell; Michael T Stang; Linwah Yip; Sally E Carty
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

8.  Direct, minimally invasive adenomectomy for primary hyperparathyroidism: An alternative to conventional neck exploration?

Authors:  P C Smit; I H Borel Rinkes; A van Dalen; T J van Vroonhoven
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

9.  The impact of vitamin D status and tumor size on the intraoperative parathyroid hormone dynamics in patients with symptomatic primary hyperparathyroidism.

Authors:  Gaurav Agarwal; Dhalapathy Sadacharan; Pooja Ramakant; Manoj Shukla; Saroj K Mishra
Journal:  Surg Today       Date:  2012-01-05       Impact factor: 2.549

10.  Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement.

Authors:  Richard E Goldstein; Dean Billheimer; William H Martin; Ken Richards
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.